Fixed Duration Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone for High Risk Smoldering Multiple Myeloma-Results of the Ascent Trial

Blood(2022)

引用 4|浏览29
暂无评分
关键词
daratumumab,lenalidomide,dexamethasone,myeloma-results
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要